ロード中...
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...
保存先:
| 出版年: | Ann Clin Microbiol Antimicrob |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6022507/ https://ncbi.nlm.nih.gov/pubmed/29950163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0281-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|